Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow Reinvestment Rate
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Reinvestment Rate of 0.56x as of March 2026, reinvesting $18.08 Million (capex $39.00K plus investments $-18.04 Million) from operating cash flow of $32.56 Million. Explore Aurinia Pharmaceuticals Inc (AUPH) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aurinia Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Aurinia Pharmaceuticals Inc across 2 annual periods. Also explore AUPH total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Aurinia Pharmaceuticals Inc (2024–2025)
Year-by-year capital reinvestment analysis for Aurinia Pharmaceuticals Inc. For live market cap and broader valuation context, see Aurinia Pharmaceuticals Inc (AUPH) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | $32.77 Million | $135.66 Million | $252.00K | ▼ -72.9% |
| 2024 | 0.89x | $39.54 Million | $44.39 Million | $281.00K | — |